Shri Ahimsa Naturals Ltd

Shri Ahimsa Naturals Ltd

₹ 158 -1.92%
30 May - close price
About

Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts.[1]

Key Points

Business Profile[1]
The Company is engaged in extracting and manufacturing Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE), and Crude Caffeine, and trading in herbal extracts. It supplies food & beverages, nutraceuticals, cosmetics, and pharmaceutical industries.

  • Market Cap 370 Cr.
  • Current Price 158
  • High / Low 173 / 126
  • Stock P/E 16.9
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 24.2 %
  • ROE 18.4 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company's working capital requirements have reduced from 125 days to 92.6 days

Cons

  • Promoter holding has decreased over last quarter: -25.6%
  • Debtor days have increased from 62.9 to 96.2 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2024 Mar 2025
41 55
27 38
Operating Profit 14 17
OPM % 34% 30%
1 1
Interest 0 1
Depreciation 1 1
Profit before tax 13 16
Tax % 26% 26%
10 12
EPS in Rs 5.09 5.23
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
104 78 96
54 51 65
Operating Profit 50 27 30
OPM % 48% 34% 32%
2 1 2
Interest 1 1 1
Depreciation 1 1 2
Profit before tax 51 25 30
Tax % 25% 26% 26%
38 19 22
EPS in Rs 72.99 10.19 9.39
Dividend Payout % 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 23%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 18%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
Equity Capital 5 18 23
Reserves 60 66 131
3 14 0
5 5 38
Total Liabilities 74 103 193
28 40 47
CWIP 4 8 4
Investments 0 0 0
42 56 142
Total Assets 74 103 193

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
20 6
-10 -17
-4 10
Net Cash Flow 7 -2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
Debtor Days 39 53 96
Inventory Days 122 340 214
Days Payable 8 18 3
Cash Conversion Cycle 154 375 308
Working Capital Days 88 195 93
ROCE % 31% 24%

Shareholding Pattern

Numbers in percentages

4 Recently
Mar 2025Apr 2025
68.68% 68.68%
3.04% 3.04%
8.59% 8.59%
19.68% 19.68%
No. of Shareholders 2,3322,332

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents